ForecastMind
Markets/FDA approves Grace Therapeutics’ GTx-104?
Share on X

FDA approves Grace Therapeutics’ GTx-104?

84%YES
16%NO
Vol 24h$999
Liquidity$5K
Bid / Ask83% / 84%
Spread1.00pp
ClosesApr 23, 2026

Wikipedia Attention

Price History · 30 days

Export CSV

Price History

+5.0pp

✦ AI Analysis

Synthesizes price, cross-venue gaps, Bayesian edge, and event context into a concise brief.

Research Summary

Prediction markets currently price "FDA approves Grace Therapeutics’ GTx-104?" at 84% YES / 16% NO. In the last 24 hours, $999 has been traded. A Bayesian estimate puts the probability at 84%. The bid-ask spread is 1.00pp. The market closes on April 23, 2026.

Cite this snapshot

ForecastMind (2026-04-18). "FDA approves Grace Therapeutics’ GTx-104?." Prediction market snapshot: YES 84%, NO 16%. Retrieved from https://forecastmind.org/markets/1993772